Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 252 entries
Sorted by: Best Match Show Resources per page
Clinical electromyography; physiologic basis, instrumentation, diagnostic value.

Archives of physical medicine and rehabilitation

HIRSCHBERG GG, ABRAMSON AS.
PMID: 15433716
Arch Phys Med Rehabil. 1950 Sep;31(9):576-87.

No abstract available.

Cite
HIRSCHBERG GG, ABRAMSON AS. Clinical electromyography; physiologic basis, instrumentation, diagnostic value. Arch Phys Med Rehabil. 1950;31(9):576-87
HIRSCHBERG, G. G., & ABRAMSON, A. S. (1950). Clinical electromyography; physiologic basis, instrumentation, diagnostic value. Archives of physical medicine and rehabilitation, 31(9), 576-87.
HIRSCHBERG, G G, and ABRAMSON, A S. "Clinical electromyography; physiologic basis, instrumentation, diagnostic value." Archives of physical medicine and rehabilitation vol. 31,9 (1950): 576-87.
HIRSCHBERG GG, ABRAMSON AS. Clinical electromyography; physiologic basis, instrumentation, diagnostic value. Arch Phys Med Rehabil. 1950 Sep;31(9):576-87. PMID: 15433716.
Copy Download .nbib Format: NLM
Fabrication of Nanoscale Bioarrays for the Study of Cytoskeletal Protein Binding Interactions Using Nanoimprint Lithography.

Journal of vacuum science & technology. B, Microelectronics and nanometer structures : processing, measurement, and phenomena : an official journal of the American Vacuum Society

Schvartzman M, Nguyen K, Palma M, Abramson J, Sable J, Hone J, Sheetz MP, Wind SJ.
PMID: 19777075
J Vac Sci Technol B Microelectron Nanometer Struct Process Meas Phenom. 2009 Jan 01;27(1):61-65. doi: 10.1116/1.3043472.

We describe a high throughput patterning process used to create arrays of molecular-scale features for the study of cytoskeletal protein binding interactions. The process uses a shadow-evaporated metal mask to facilitate lift-off of features defined by nanoimprint lithography. This...

Cite
Schvartzman M, Nguyen K, Palma M, et al. Fabrication of Nanoscale Bioarrays for the Study of Cytoskeletal Protein Binding Interactions Using Nanoimprint Lithography. J Vac Sci Technol B Microelectron Nanometer Struct Process Meas Phenom. 2009;27(1):61-65doi: 10.1116/1.3043472.
Schvartzman, M., Nguyen, K., Palma, M., Abramson, J., Sable, J., Hone, J., Sheetz, M. P., & Wind, S. J. (2009). Fabrication of Nanoscale Bioarrays for the Study of Cytoskeletal Protein Binding Interactions Using Nanoimprint Lithography. Journal of vacuum science & technology. B, Microelectronics and nanometer structures : processing, measurement, and phenomena : an official journal of the American Vacuum Society, 27(1), 61-65. https://doi.org/10.1116/1.3043472
Schvartzman, M, et al. "Fabrication of Nanoscale Bioarrays for the Study of Cytoskeletal Protein Binding Interactions Using Nanoimprint Lithography." Journal of vacuum science & technology. B, Microelectronics and nanometer structures : processing, measurement, and phenomena : an official journal of the American Vacuum Society vol. 27,1 (2009): 61-65. doi: https://doi.org/10.1116/1.3043472
Schvartzman M, Nguyen K, Palma M, Abramson J, Sable J, Hone J, Sheetz MP, Wind SJ. Fabrication of Nanoscale Bioarrays for the Study of Cytoskeletal Protein Binding Interactions Using Nanoimprint Lithography. J Vac Sci Technol B Microelectron Nanometer Struct Process Meas Phenom. 2009 Jan 01;27(1):61-65. doi: 10.1116/1.3043472. PMID: 19777075; PMCID: PMC2748349.
Copy Download .nbib Format: NLM
Topical treatment options for conjunctival neoplasms.

Clinical ophthalmology (Auckland, N.Z.)

Kim JW, Abramson DH.
PMID: 19668748
Clin Ophthalmol. 2008 Sep;2(3):503-15. doi: 10.2147/opth.s1606.

Topical therapies offer a nonsurgical method for treating conjunctival tumors by delivering high drug concentrations to the ocular surface. Over the past ten years, topical agents have been used by investigators to treat various premalignant and malignant lesions of...

Cite
Kim JW, Abramson DH. Topical treatment options for conjunctival neoplasms. Clin Ophthalmol. 2008;2(3):503-15doi: 10.2147/opth.s1606.
Kim, J. W., & Abramson, D. H. (2008). Topical treatment options for conjunctival neoplasms. Clinical ophthalmology (Auckland, N.Z.), 2(3), 503-15. https://doi.org/10.2147/opth.s1606
Kim, Jonathan W, and Abramson, David H. "Topical treatment options for conjunctival neoplasms." Clinical ophthalmology (Auckland, N.Z.) vol. 2,3 (2008): 503-15. doi: https://doi.org/10.2147/opth.s1606
Kim JW, Abramson DH. Topical treatment options for conjunctival neoplasms. Clin Ophthalmol. 2008 Sep;2(3):503-15. doi: 10.2147/opth.s1606. PMID: 19668748; PMCID: PMC2694026.
Copy Download .nbib Format: NLM
Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature.

Primary care companion to the Journal of clinical psychiatry

Abramson DW, Quinn DK, Stern TA.
PMID: 19287558
Prim Care Companion J Clin Psychiatry. 2008;10(6):470-6. doi: 10.4088/pcc.v10n0609.

No abstract available.

Cite
Abramson DW, Quinn DK, Stern TA. Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature. Prim Care Companion J Clin Psychiatry. 2008;10(6):470-6doi: 10.4088/pcc.v10n0609.
Abramson, D. W., Quinn, D. K., & Stern, T. A. (2008). Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature. Primary care companion to the Journal of clinical psychiatry, 10(6), 470-6. https://doi.org/10.4088/pcc.v10n0609
Abramson, David W, et al. "Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature." Primary care companion to the Journal of clinical psychiatry vol. 10,6 (2008): 470-6. doi: https://doi.org/10.4088/pcc.v10n0609
Abramson DW, Quinn DK, Stern TA. Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature. Prim Care Companion J Clin Psychiatry. 2008;10(6):470-6. doi: 10.4088/pcc.v10n0609. PMID: 19287558; PMCID: PMC2644474.
Copy Download .nbib Format: NLM
Unanswered Questions in HIV Hematology.

Advances in hematology

Leitch HA, Abramson JS, Cheung MC, Hicks LK.
PMID: 22745641
Adv Hematol. 2012;2012:907025. doi: 10.1155/2012/907025. Epub 2012 Jun 04.

No abstract available.

Cite
Leitch HA, Abramson JS, Cheung MC, et al. Unanswered Questions in HIV Hematology. Adv Hematol. 2012;2012:907025doi: 10.1155/2012/907025.
Leitch, H. A., Abramson, J. S., Cheung, M. C., & Hicks, L. K. (2012). Unanswered Questions in HIV Hematology. Advances in hematology, 2012907025. https://doi.org/10.1155/2012/907025
Leitch, Heather A, et al. "Unanswered Questions in HIV Hematology." Advances in hematology vol. 2012 (2012): 907025. doi: https://doi.org/10.1155/2012/907025
Leitch HA, Abramson JS, Cheung MC, Hicks LK. Unanswered Questions in HIV Hematology. Adv Hematol. 2012;2012:907025. doi: 10.1155/2012/907025. Epub 2012 Jun 04. PMID: 22745641; PMCID: PMC3382958.
Copy Download .nbib Format: NLM
Patterns in wireless phone estimation data from a cross-sectional survey: what are the implications for epidemiology?.

BMJ open

Redmayne M, Smith E, Abramson MJ.
PMID: 22952160
BMJ Open. 2012 Sep 04;2(5). doi: 10.1136/bmjopen-2012-000887. Print 2012.

OBJECTIVE: Self-reported recall data are often used in wireless phone epidemiological studies, which in turn are used to indicate relative risk of health outcomes from extended radiofrequency exposure. We sought to explain features commonly observed in wireless phone recall...

Cite
Redmayne M, Smith E, Abramson MJ. Patterns in wireless phone estimation data from a cross-sectional survey: what are the implications for epidemiology?. BMJ Open. 2012;2(5)doi: 10.1136/bmjopen-2012-000887.
Redmayne, M., Smith, E., & Abramson, M. J. (2012). Patterns in wireless phone estimation data from a cross-sectional survey: what are the implications for epidemiology?. BMJ open, 2(5), . https://doi.org/10.1136/bmjopen-2012-000887
Redmayne, Mary, et al. "Patterns in wireless phone estimation data from a cross-sectional survey: what are the implications for epidemiology?." BMJ open vol. 2,5 (2012). doi: https://doi.org/10.1136/bmjopen-2012-000887
Redmayne M, Smith E, Abramson MJ. Patterns in wireless phone estimation data from a cross-sectional survey: what are the implications for epidemiology?. BMJ Open. 2012 Sep 04;2(5). doi: 10.1136/bmjopen-2012-000887. Print 2012. PMID: 22952160; PMCID: PMC3437435.
Copy Download .nbib Format: NLM
Choroidal infarction following ophthalmic artery chemotherapy.

International journal of retina and vitreous

Bohm KJ, Gobin YP, Francis JH, McInerney G, Dabo-Trubelja A, Dalecki PH, Marr BP, Abramson DH.
PMID: 29736261
Int J Retina Vitreous. 2018 Apr 30;4:16. doi: 10.1186/s40942-018-0119-x. eCollection 2018.

BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) genetic mutations and intra-procedural inhaled nitrous oxide (NCASE PRESENTATIONS: Single-center retrospective review of pediatric patients with advanced retinoblastoma who received OAC and developed choroidal infarcts. Four retinoblastoma patients with advanced intraocular disease (2 males, 2...

Cite
Bohm KJ, Gobin YP, Francis JH, et al. Choroidal infarction following ophthalmic artery chemotherapy. Int J Retina Vitreous. 2018;4:16doi: 10.1186/s40942-018-0119-x.
Bohm, K. J., Gobin, Y. P., Francis, J. H., McInerney, G., Dabo-Trubelja, A., Dalecki, P. H., Marr, B. P., & Abramson, D. H. (2018). Choroidal infarction following ophthalmic artery chemotherapy. International journal of retina and vitreous, 416. https://doi.org/10.1186/s40942-018-0119-x
Bohm, Kelley J, et al. "Choroidal infarction following ophthalmic artery chemotherapy." International journal of retina and vitreous vol. 4 (2018): 16. doi: https://doi.org/10.1186/s40942-018-0119-x
Bohm KJ, Gobin YP, Francis JH, McInerney G, Dabo-Trubelja A, Dalecki PH, Marr BP, Abramson DH. Choroidal infarction following ophthalmic artery chemotherapy. Int J Retina Vitreous. 2018 Apr 30;4:16. doi: 10.1186/s40942-018-0119-x. eCollection 2018. PMID: 29736261; PMCID: PMC5925835.
Copy Download .nbib Format: NLM
Authors' response to 2017-199 LtoEd.

Australian and New Zealand journal of public health

Benke G, Bhatt C, Abramson MJ.
PMID: 29235716
Aust N Z J Public Health. 2018 Feb;42(1):113. doi: 10.1111/1753-6405.12757. Epub 2017 Dec 13.

No abstract available.

Cite
Benke G, Bhatt C, Abramson MJ. Authors' response to 2017-199 LtoEd. Aust N Z J Public Health. 2017;42(1):113doi: 10.1111/1753-6405.12757.
Benke, G., Bhatt, C., & Abramson, M. J. (2018). Authors' response to 2017-199 LtoEd. Australian and New Zealand journal of public health, 42(1), 113. https://doi.org/10.1111/1753-6405.12757
Benke, Geza, et al. "Authors' response to 2017-199 LtoEd." Australian and New Zealand journal of public health vol. 42,1 (2018): 113. doi: https://doi.org/10.1111/1753-6405.12757
Benke G, Bhatt C, Abramson MJ. Authors' response to 2017-199 LtoEd. Aust N Z J Public Health. 2018 Feb;42(1):113. doi: 10.1111/1753-6405.12757. Epub 2017 Dec 13. PMID: 29235716.
Copy Download .nbib Format: NLM
Ion Transport across Biological Membranes by Carborane-Capped Gold Nanoparticles.

ACS nano

Grzelczak MP, Danks SP, Klipp RC, Belic D, Zaulet A, Kunstmann-Olsen C, Bradley DF, Tsukuda T, Viñas C, Teixidor F, Abramson JJ, Brust M.
PMID: 29161496
ACS Nano. 2017 Dec 26;11(12):12492-12499. doi: 10.1021/acsnano.7b06600. Epub 2017 Nov 28.

Carborane-capped gold nanoparticles (Au/carborane NPs, 2-3 nm) can act as artificial ion transporters across biological membranes. The particles themselves are large hydrophobic anions that have the ability to disperse in aqueous media and to partition over both sides of...

Cite
Grzelczak MP, Danks SP, Klipp RC, et al. Ion Transport across Biological Membranes by Carborane-Capped Gold Nanoparticles. ACS Nano. 2017;11(12):12492-12499doi: 10.1021/acsnano.7b06600.
Grzelczak, M. P., Danks, S. P., Klipp, R. C., Belic, D., Zaulet, A., Kunstmann-Olsen, C., Bradley, D. F., Tsukuda, T., Viñas, C., Teixidor, F., Abramson, J. J., & Brust, M. (2017). Ion Transport across Biological Membranes by Carborane-Capped Gold Nanoparticles. ACS nano, 11(12), 12492-12499. https://doi.org/10.1021/acsnano.7b06600
Grzelczak, Marcin P, et al. "Ion Transport across Biological Membranes by Carborane-Capped Gold Nanoparticles." ACS nano vol. 11,12 (2017): 12492-12499. doi: https://doi.org/10.1021/acsnano.7b06600
Grzelczak MP, Danks SP, Klipp RC, Belic D, Zaulet A, Kunstmann-Olsen C, Bradley DF, Tsukuda T, Viñas C, Teixidor F, Abramson JJ, Brust M. Ion Transport across Biological Membranes by Carborane-Capped Gold Nanoparticles. ACS Nano. 2017 Dec 26;11(12):12492-12499. doi: 10.1021/acsnano.7b06600. Epub 2017 Nov 28. PMID: 29161496; PMCID: PMC5746845.
Copy Download .nbib Format: NLM
An eco-friendly route to magnetic silica microspheres and nanospheres.

Journal of colloid and interface science

Abramson S, Safraou W, Malezieux B, Dupuis V, Borensztajn S, Briot E, Bée A.
PMID: 21925671
J Colloid Interface Sci. 2011 Dec 15;364(2):324-32. doi: 10.1016/j.jcis.2011.08.056. Epub 2011 Aug 28.

A green and inexpensive alternative to existing methods for the preparation of magnetic iron oxide/silica nanocomposite particles has been investigated. The use of water-in oil emulsions based on vegetable oils instead of usual solvents led to microsized or nanosized...

Cite
Abramson S, Safraou W, Malezieux B, et al. An eco-friendly route to magnetic silica microspheres and nanospheres. J Colloid Interface Sci. 2011;364(2):324-32doi: 10.1016/j.jcis.2011.08.056.
Abramson, S., Safraou, W., Malezieux, B., Dupuis, V., Borensztajn, S., Briot, E., & Bée, A. (2011). An eco-friendly route to magnetic silica microspheres and nanospheres. Journal of colloid and interface science, 364(2), 324-32. https://doi.org/10.1016/j.jcis.2011.08.056
Abramson, Sébastien, et al. "An eco-friendly route to magnetic silica microspheres and nanospheres." Journal of colloid and interface science vol. 364,2 (2011): 324-32. doi: https://doi.org/10.1016/j.jcis.2011.08.056
Abramson S, Safraou W, Malezieux B, Dupuis V, Borensztajn S, Briot E, Bée A. An eco-friendly route to magnetic silica microspheres and nanospheres. J Colloid Interface Sci. 2011 Dec 15;364(2):324-32. doi: 10.1016/j.jcis.2011.08.056. Epub 2011 Aug 28. PMID: 21925671.
Copy Download .nbib Format: NLM
Honey Bee Location- and Time-Linked Memory Use in Novel Foraging Situations: Floral Color Dependency.

Insects

Amaya-Márquez M, Hill PS, Abramson CI, Wells H.
PMID: 26462587
Insects. 2014 Feb 14;5(1):243-69. doi: 10.3390/insects5010243.

Learning facilitates behavioral plasticity, leading to higher success rates when foraging. However, memory is of decreasing value with changes brought about by moving to novel resource locations or activity at different times of the day. These premises suggest a...

Cite
Amaya-Márquez M, Hill PS, Abramson CI, et al. Honey Bee Location- and Time-Linked Memory Use in Novel Foraging Situations: Floral Color Dependency. Insects. 2014;5(1):243-69doi: 10.3390/insects5010243.
Amaya-Márquez, M., Hill, P. S., Abramson, C. I., & Wells, H. (2014). Honey Bee Location- and Time-Linked Memory Use in Novel Foraging Situations: Floral Color Dependency. Insects, 5(1), 243-69. https://doi.org/10.3390/insects5010243
Amaya-Márquez, Marisol, et al. "Honey Bee Location- and Time-Linked Memory Use in Novel Foraging Situations: Floral Color Dependency." Insects vol. 5,1 (2014): 243-69. doi: https://doi.org/10.3390/insects5010243
Amaya-Márquez M, Hill PS, Abramson CI, Wells H. Honey Bee Location- and Time-Linked Memory Use in Novel Foraging Situations: Floral Color Dependency. Insects. 2014 Feb 14;5(1):243-69. doi: 10.3390/insects5010243. PMID: 26462587; PMCID: PMC4592622.
Copy Download .nbib Format: NLM
Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab.

American journal of ophthalmology case reports

Francis JH, Slakter JS, Abramson DH, Odrich SA, Gobin YP.
PMID: 29978140
Am J Ophthalmol Case Rep. 2018 May 24;11:49-51. doi: 10.1016/j.ajoc.2018.05.007. eCollection 2018 Sep.

PURPOSE: To report on two cases of treatment-refractory juxtapapillary hemagioblastomas that were managed with intra-arterial bevacizumab delivered via the ophthalmic artery.OBSERVATIONS: Case 1 is a 35 year-old man with juxtapapillary hemangioblastoma who continued to have progressive tractional retinal detachment,...

Cite
Francis JH, Slakter JS, Abramson DH, et al. Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab. Am J Ophthalmol Case Rep. 2018;11:49-51doi: 10.1016/j.ajoc.2018.05.007.
Francis, J. H., Slakter, J. S., Abramson, D. H., Odrich, S. A., & Gobin, Y. P. (2018). Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab. American journal of ophthalmology case reports, 1149-51. https://doi.org/10.1016/j.ajoc.2018.05.007
Francis, Jasmine H, et al. "Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab." American journal of ophthalmology case reports vol. 11 (2018): 49-51. doi: https://doi.org/10.1016/j.ajoc.2018.05.007
Francis JH, Slakter JS, Abramson DH, Odrich SA, Gobin YP. Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab. Am J Ophthalmol Case Rep. 2018 May 24;11:49-51. doi: 10.1016/j.ajoc.2018.05.007. eCollection 2018 Sep. PMID: 29978140; PMCID: PMC6026768.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 252 entries